The World Health Organization (WHO) International Standard for HIV-1 RNA nucleic acid assays was characterized by complete genome deep sequencing analysis. The entire coding sequence and flanking long terminal repeats (LTRs), including minority species, were assigned subtype B. This information will aid the design, development, and evaluation of HIV-1 RNA amplification assays
The highly variable genome of the Human Immunodeficiency Virus Type-1 (HIV-1) has been extensively s...
Background: With an estimated 38 million people worldwide currently infected with human immunodefici...
The goal of the study was to improve the methodology of HIV genotyping for analysis of HIV drug resi...
TheWorld Health Organization (WHO) International Standard for HIV-1 RNA nucleic acid assays was char...
Sequencing very long stretches of the HIV-1 genome can advance studies on virus evolution and in viv...
AbstractThe BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe) project aims to analy...
The BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe) project aims to analyse nearl...
We describe a detailed protocol for the manual workup of blood (plasma/serum) samples from individua...
India has the third largest number of HIV-1-infected individuals accounting for approximately 2.1 mi...
Introduction: HIV-1 near full-length genome (HIV-NFLG) sequencing from plasma is an attractive multi...
With an estimated 38 million people worldwide currently infected with human immunodeficiency virus (...
Background The advent of near full-length (NFL) HIV-1 proviral genome sequencing greatly expanded ou...
With an estimated 38 million people worldwide currently infected with human immunodeficiency virus (...
Near full genome sequencing (NFGS) of HIV-1 is required to assess the genetic composition of HIV-1 s...
Nearly full-length genome sequencing of HIV-1 using peripheral blood mononuclear cells (PBMC) DNA as...
The highly variable genome of the Human Immunodeficiency Virus Type-1 (HIV-1) has been extensively s...
Background: With an estimated 38 million people worldwide currently infected with human immunodefici...
The goal of the study was to improve the methodology of HIV genotyping for analysis of HIV drug resi...
TheWorld Health Organization (WHO) International Standard for HIV-1 RNA nucleic acid assays was char...
Sequencing very long stretches of the HIV-1 genome can advance studies on virus evolution and in viv...
AbstractThe BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe) project aims to analy...
The BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe) project aims to analyse nearl...
We describe a detailed protocol for the manual workup of blood (plasma/serum) samples from individua...
India has the third largest number of HIV-1-infected individuals accounting for approximately 2.1 mi...
Introduction: HIV-1 near full-length genome (HIV-NFLG) sequencing from plasma is an attractive multi...
With an estimated 38 million people worldwide currently infected with human immunodeficiency virus (...
Background The advent of near full-length (NFL) HIV-1 proviral genome sequencing greatly expanded ou...
With an estimated 38 million people worldwide currently infected with human immunodeficiency virus (...
Near full genome sequencing (NFGS) of HIV-1 is required to assess the genetic composition of HIV-1 s...
Nearly full-length genome sequencing of HIV-1 using peripheral blood mononuclear cells (PBMC) DNA as...
The highly variable genome of the Human Immunodeficiency Virus Type-1 (HIV-1) has been extensively s...
Background: With an estimated 38 million people worldwide currently infected with human immunodefici...
The goal of the study was to improve the methodology of HIV genotyping for analysis of HIV drug resi...